Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""La Hoz RM"" wg kryterium: Autor


Tytuł:
Transplant of organs from donors with positive SARS-CoV-2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee.
Autorzy:
Goldman JD; Organ Transplant and Liver Center, Swedish Medical Center, Seattle, Washington, USA.; Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.
Pouch SM; Emory University School of Medicine, Atlanta, Georgia, USA.
Woolley AE; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Booker SE; United Network for Organ Sharing, Richmond, Virginia, USA.
Jett CT; United Network for Organ Sharing, Richmond, Virginia, USA.
Fox C; United Network for Organ Sharing, Richmond, Virginia, USA.
Berry GJ; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
Dunn KE; Yale New Haven Hospital, New Haven, Connecticut, USA.
Ho CS; Gift of Hope Organ and Tissue Donor Network, Itasca, Illinois, USA.; College of Human Medicine, Michigan State University, East Lansing, Michigan, USA.
Kittleson M; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Lee DH; Division of Infectious Diseases, University of California San Francisco, San Francisco, California, USA.
Levine DJ; Department of Medicine, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA.
Marboe CC; Department of Pathology and Cell Biology, Columbia University New York, New York, New York, USA.
Marklin G; Mid-America Transplant, St. Louis, Missouri, USA.
Razonable RR; Division of Public Health, Infectious Diseases and Occupational Medicine and the William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, Minnesota, USA.
Taimur S; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Te HS; Center for Liver Diseases, University of Chicago Medicine, Chicago, Illinois, USA.
Anesi JA; Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Fisher CE; Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.
Sellers MT; DCI Donor Services, Inc., Nashville, Tennessee, USA.
Trindade AJ; Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Wood RP; LifeGift Organ Donation Center, Houston, Texas, USA.
Zaffiri L; Department of Medicine, Duke University, Durham, North Carolina, USA.
Levi ME; Division of Transplantation, Health Systems Bureau, Health Resources and Services Administration, Rockville, Maryland, USA.
Klassen D; Office of the Chief Medical Officer, United Network for Organ Sharing, Richmond, Virginia, USA.
Michaels MG; Department of Pediatrics, School of Medicine, University of Pittsburg, Pittsburg, Pennsylvania, USA.
La Hoz RM; Division of Infectious Disease and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Danziger-Isakov L; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2023 Feb; Vol. 25 (1), pp. e14013. Date of Electronic Publication: 2023 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
Nucleic Acids*
COVID-19*
Tissue and Organ Procurement*
Organ Transplantation*
Humans ; SARS-CoV-2 ; Advisory Committees ; Tissue Donors
Czasopismo naukowe
Tytuł:
SARS-CoV-2 NAT+ donors for pediatric solid organ transplant recipients-Are they safe and provide good outcomes?
Autorzy:
La Hoz RM; Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Green M; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Pokaż więcej
Źródło:
Pediatric transplantation [Pediatr Transplant] 2022 Dec; Vol. 26 (8), pp. e14406. Date of Electronic Publication: 2022 Oct 04.
Typ publikacji:
Editorial; Comment
MeSH Terms:
COVID-19*
Organ Transplantation*
Humans ; Child ; SARS-CoV-2 ; Transplant Recipients ; Tissue Donors
Opinia redakcyjna
Tytuł:
Short-term kidney transplant outcomes from severe acute respiratory syndrome coronavirus 2 lower respiratory tract positive donors.
Autorzy:
Sanchez-Vivaldi JA; Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Patel MS; Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Shah JA; Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Wang BK; Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Salcedo-Betancourt JD; Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Hwang CS; Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Wojciechowski D; Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
La Hoz RM; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Vagefi PA; Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2022 Aug; Vol. 24 (4), pp. e13890. Date of Electronic Publication: 2022 Jul 12.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Kidney Transplantation*/adverse effects
Humans ; Respiratory System ; SARS-CoV-2 ; Tissue Donors
Czasopismo naukowe
Tytuł:
Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Through Solid Organ Transplantation and Outcomes of Coronavirus Disease 2019 Among Recent Transplant Recipients.
Autorzy:
Free RJ; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Annambhotla P; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
La Hoz RM; Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Danziger-Isakov L; Department of Pediatrics, Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio, USA.
Jones JM; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Wang L; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Sankthivel S; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Levi ME; Division of Transplantation, Health Systems Bureau, Health Resources and Services Administration, Rockville, Maryland, USA.
Michaels MG; Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Kuhnert W; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Klassen D; United Network for Organ Sharing, Richmond, Virginia, USA.
Basavaraju SV; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Kracalik IT; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2022 May 02; Vol. 9 (7), pp. ofac221. Date of Electronic Publication: 2022 May 02 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Characteristics and outcomes among vaccinated lung transplant patients with breakthrough COVID-19.
Autorzy:
Bollineni S; Department of Internal Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Mahan LD; Department of Internal Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Duncan P; Department of Internal Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Mohanka MR; Department of Internal Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Lawrence A; Department of Internal Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Joerns J; Department of Internal Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Timofte I; Department of Internal Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Torres F; Department of Internal Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
La Hoz RM; Infectious Disease and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Kershaw CD; Department of Internal Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Terada LS; Department of Internal Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Kaza V; Department of Internal Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Banga A; Department of Internal Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2022 Apr; Vol. 24 (2), pp. e13784. Date of Electronic Publication: 2022 Jan 19.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
Lung Transplantation*/adverse effects
Adult ; Humans ; Middle Aged ; SARS-CoV-2 ; Vaccination ; Vaccines, Synthetic ; mRNA Vaccines
Czasopismo naukowe
Tytuł:
Donor-derived tuberculosis among solid organ transplant recipients in the United States-2008 to 2018.
Autorzy:
Malinis M; Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
La Hoz RM; Division of Infectious Disease and Geographic Medicine, University of Texas Southwestern, Dallas, Texas.
Vece G; United Network for Organ Sharing, Richmond, Virginia.
Annambhotla P; Centers for Disease Control Prevention, Atlanta, Georgia.
Aslam S; Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California.
Basavaraju SV; Centers for Disease Control Prevention, Atlanta, Georgia.
Bucio J; University of Chicago, Chicago, Illinois.
Danziger-Isakov L; Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio.
Florescu DF; Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Lincoln, Nebraska.
Jones JM; Centers for Disease Control Prevention, Atlanta, Georgia.
Rana M; Division of Infectious Diseases, Mount Sinai School of Medicine, New York, New York.
Wolfe CR; Division of Infectious Diseases, Duke University, Durham, North Carolina.
Michaels MG; Department of Pediatrics, UPMC Children's Hospital of Pittsburgh and University of Pittsburgh, Pittsburgh, Pennsylvania.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2022 Apr; Vol. 24 (2), pp. e13800. Date of Electronic Publication: 2022 Feb 04.
Typ publikacji:
Journal Article
MeSH Terms:
Organ Transplantation*/adverse effects
Tissue and Organ Procurement*
Tuberculosis*/diagnosis
Humans ; Tissue Donors ; Transplant Recipients ; United States/epidemiology
Czasopismo naukowe
Tytuł:
Predictors and outcomes of respiratory failure among lung transplant patients with COVID-19.
Autorzy:
Lawrence A; Divisions of Pulmonary and Critical Care Medicine, Dallas, Texas, USA.
Mahan LD; Divisions of Pulmonary and Critical Care Medicine, Dallas, Texas, USA.
Mohanka MR; Divisions of Pulmonary and Critical Care Medicine, Dallas, Texas, USA.
Bollineni S; Divisions of Pulmonary and Critical Care Medicine, Dallas, Texas, USA.
Kaza V; Divisions of Pulmonary and Critical Care Medicine, Dallas, Texas, USA.
La Hoz RM; Infectious Disease and Geographic Medicine, Dallas, Texas, USA.
Zhang S; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Kershaw CD; Divisions of Pulmonary and Critical Care Medicine, Dallas, Texas, USA.
Terada LS; Divisions of Pulmonary and Critical Care Medicine, Dallas, Texas, USA.
Torres F; Divisions of Pulmonary and Critical Care Medicine, Dallas, Texas, USA.
Banga A; Divisions of Pulmonary and Critical Care Medicine, Dallas, Texas, USA.
Pokaż więcej
Źródło:
Clinical transplantation [Clin Transplant] 2022 Mar; Vol. 36 (3), pp. e14540. Date of Electronic Publication: 2021 Dec 05.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
Lung Transplantation*/adverse effects
Respiratory Insufficiency*/etiology
Humans ; Respiration, Artificial ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Short-term liver transplant outcomes from SARS-CoV-2 lower respiratory tract NAT positive donors.
Autorzy:
La Hoz RM; Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Mufti AR; Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Vagefi PA; Division of Surgical Transplantation, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2022 Feb; Vol. 24 (1), pp. e13757. Date of Electronic Publication: 2021 Dec 14.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Liver Transplantation*/adverse effects
Nucleic Acids*
COVID-19 Testing ; Humans ; SARS-CoV-2 ; Tissue Donors ; United States
Czasopismo naukowe
Tytuł:
Daptomycin-Resistant Enterococcus Bacteremia Is Associated With Prior Daptomycin Use and Increased Mortality After Liver Transplantation.
Autorzy:
Lee RA; University of Alabama at Birmingham, Birmingham, Alabama, USA.
Goldman J; Swedish Medical Center, Seattle, Washington, USA.
Haidar G; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Lewis J; Medical University of South Carolina, Charleston, South Carolina, USA.
Arif S; Duke University, Durham, North Carolina, USA.
Hand J; Oschner Health, New Orleans, Louisiana, USA.
La Hoz RM; University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Pouch S; Emory University, Atlanta, Georgia, USA.
Holaday E; Temple University, Philadelphia, Pennsylvania, USA.
Clauss H; Temple University, Philadelphia, Pennsylvania, USA.
Kaye KS; University of Michigan, Ann Arbor, Michigan, USA.
Nellore A; University of Alabama at Birmingham, Birmingham, Alabama, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2022 Jan 22; Vol. 9 (3), pp. ofab659. Date of Electronic Publication: 2022 Jan 22 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Post-infection pulmonary sequelae after COVID-19 among patients with lung transplantation.
Autorzy:
Mahan LD; Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, University of Texas System, Dallas, Texas, USA.
Lill I; Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, University of Texas System, Dallas, Texas, USA.
Halverson Q; Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, University of Texas System, Dallas, Texas, USA.
Mohanka MR; Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, University of Texas System, Dallas, Texas, USA.
Lawrence A; Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, University of Texas System, Dallas, Texas, USA.
Joerns J; Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, University of Texas System, Dallas, Texas, USA.
Bollineni S; Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, University of Texas System, Dallas, Texas, USA.
Kaza V; Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, University of Texas System, Dallas, Texas, USA.
La Hoz RM; Infectious Disease and Geographic Medicine, University of Texas Southwestern Medical Center, University of Texas System, Dallas, Texas, USA.
Zhang S; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, University of Texas System, Dallas, Texas, USA.
Kershaw CD; Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, University of Texas System, Dallas, Texas, USA.
Terada LS; Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, University of Texas System, Dallas, Texas, USA.
Torres F; Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, University of Texas System, Dallas, Texas, USA.
Banga A; Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, University of Texas System, Dallas, Texas, USA.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2021 Dec; Vol. 23 (6), pp. e13739. Date of Electronic Publication: 2021 Oct 17.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Lung Transplantation*/adverse effects
Follow-Up Studies ; Humans ; Lung/diagnostic imaging ; Retrospective Studies ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Characteristics and outcomes among lung transplant patients with respiratory syncytial virus infection.
Autorzy:
Mahan LD; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Points A; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Mohanka MR; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Bollineni S; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Joerns J; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Kaza V; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
La Hoz RM; Division of Infectious Disease and Geographic Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Gao A; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Zhang S; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Torres F; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Banga A; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2021 Aug; Vol. 23 (4), pp. e13661. Date of Electronic Publication: 2021 Jun 22.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Transplantation*/adverse effects
Respiratory Syncytial Virus Infections*
Adult ; Aged ; Cohort Studies ; Humans ; Lung ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients.
Autorzy:
Linder KA; Division of Infectious Disease, University of Michigan, Ann Arbor, Michigan, USA.
Kovacs C; Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio, USA.
Mullane KM; Department of Medicine, University of Chicago, Chicago, Illinois, USA.
Wolfe C; Division of Infectious Disease and International Health, Duke University, Durham, North Carolina, USA.
Clark NM; Division of Infectious Disease, Loyola University, Chicago, Illinois, USA.
La Hoz RM; Division of Infectious Disease, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Smith J; Division of Infectious Disease, University of Wisconsin, Madison, Wisconsin, USA.
Kotton CN; Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts, USA.
Limaye AP; Division of Allergy and Infectious Disease, University of Washington, Seattle, Washington, USA.
Malinis M; Section of Infectious Disease, Yale University, New Haven, Connecticut, USA.
Hakki M; Division of Infectious Disease, Oregon Health and Science University, Portland, Oregon, USA.
Mishkin A; Division of Infectious Disease, Temple University, Philadelphia, Pennsylvania, USA.
Gonzalez AA; West Coast ID, Safety Harbor, Florida, USA.
Prono MD; Division of Infectious Disease, Johns Hopkins University, Baltimore, Maryland, USA.
Ostrander D; Division of Infectious Disease, Johns Hopkins University, Baltimore, Maryland, USA.
Avery R; Division of Infectious Disease, Johns Hopkins University, Baltimore, Maryland, USA.
Kaul DR; Division of Infectious Disease, University of Michigan, Ann Arbor, Michigan, USA.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2021 Aug; Vol. 23 (4), pp. e13687. Date of Electronic Publication: 2021 Jul 20.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Cytomegalovirus Infections*/drug therapy
Hematopoietic Stem Cell Transplantation*/adverse effects
Acetates/therapeutic use ; Antiviral Agents/therapeutic use ; Humans ; Quinazolines ; Transplant Recipients ; Viral Load
Czasopismo naukowe
Tytuł:
Unexpected Hepatitis B Virus Infection After Liver Transplantation - United States, 2014-2019.
Autorzy:
Bixler D
Annambhotla P
Montgomery MP
Mixon-Hayden T
Kupronis B
Michaels MG
La Hoz RM
Basavaraju SV
Kamili S
Moorman A
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2021 Jul 09; Vol. 70 (27), pp. 961-966. Date of Electronic Publication: 2021 Jul 09.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B/*epidemiology
Liver Transplantation/*adverse effects
Adult ; Female ; Humans ; Male ; Middle Aged ; Risk-Taking ; Tissue Donors/psychology ; Tissue Donors/statistics & numerical data ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł:
Epidemiology and risk factors for varicella zoster virus reactivation in heart transplant recipients.
Autorzy:
La Hoz RM; Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Wallace A; University of Texas Southwestern Medical School, Dallas, TX, USA.
Barros N; Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, IN, USA.
Xie D; Academic Information Systems-Information Resources, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Hynan LS; Departments of Populations and Data Sciences (Biostatistics) and Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Liu T; University of Texas Southwestern Medical School, Dallas, TX, USA.
Yek C; Department of Critical Care Medicine, National Institutes of Health, Bethesda, MD, USA.
Schexnayder S; UT Southwestern Medical Center, Dallas, TX, USA.
Grodin JL; Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Garg S; Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Drazner MH; Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Peltz M; Department of Cardiothoracic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Haley RW; Division of Epidemiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Greenberg DE; Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2021 Jun; Vol. 23 (3), pp. e13519. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji:
Journal Article
MeSH Terms:
Cytomegalovirus Infections*/epidemiology
Heart Transplantation*
Herpes Zoster*
Adult ; Herpesvirus 3, Human ; Humans ; Risk Factors
Czasopismo naukowe
Tytuł:
Impact of pre-transplant carbapenem-resistant Enterobacterales colonization and/or infection on solid organ transplant outcomes.
Autorzy:
Taimur S; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Pouch SM; Emory University School of Medicine, Atlanta, GA, USA.
Zubizarreta N; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Mazumdar M; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Rana M; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Patel G; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Freire MP; Sao Paulo University, Sao Paulo, Brazil.
Pellett Madan R; New York University School of Medicine, New York, NY, USA.
Kwak EJ; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Blumberg E; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Satlin MJ; Weill Cornell Medicine, New York, NY, USA.
Pisney L; University of Colorado School of Medicine, Aurora, CO, USA.
Clemente WT; Federal University of Minas Gerais, Belo Horizonte, Brazil.
Zervos MJ; Henry Ford Health System, Detroit, MI, USA.
La Hoz RM; University of Texas Southwestern Medical Center, Dallas, TX, USA.
Huprikar S; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Pokaż więcej
Źródło:
Clinical transplantation [Clin Transplant] 2021 Apr; Vol. 35 (4), pp. e14239. Date of Electronic Publication: 2021 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Carbapenems*
Organ Transplantation*/adverse effects
Adult ; Anti-Bacterial Agents/therapeutic use ; Cohort Studies ; Humans ; Klebsiella pneumoniae ; Transplant Recipients
Czasopismo naukowe
Tytuł:
Tedizolid vs Linezolid for the Treatment of Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients.
Autorzy:
Poon YK; Department of Pharmacy, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
La Hoz RM; Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Hynan LS; Department of Population & Data Sciences (Biostatistics), University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Sanders J; Department of Pharmacy, University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Monogue ML; Department of Pharmacy, University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2021 Mar 06; Vol. 8 (4), pp. ofab093. Date of Electronic Publication: 2021 Mar 06 (Print Publication: 2021).
Typ publikacji:
Case Reports
Raport
Tytuł:
SARS-CoV-2 Infections among Recent Organ Recipients, March-May 2020, United States.
Autorzy:
Jones JM
Kracalik I
Rana MM
Nguyen A
Keller BC
Mishkin A
Hoopes C
Kaleekal T
Humar A
Vilaro J
Im G
Smith L
Justice A
Leaumont C
Lindstrom S
Whitaker B
La Hoz RM
Michaels MG
Klassen D
Kuhnert W
Basavaraju SV
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2021 Feb; Vol. 27 (2), pp. 552-555. Date of Electronic Publication: 2020 Dec 16.
Typ publikacji:
Journal Article
MeSH Terms:
SARS-CoV-2*
COVID-19/*epidemiology
Organ Transplantation/*adverse effects
Postoperative Complications/*virology
Aged ; COVID-19/virology ; Female ; Humans ; Male ; Middle Aged ; United States/epidemiology
Czasopismo naukowe
Tytuł:
Donor derived hepatitis B virus infection: Analysis of the Organ Procurement & Transplantation Network/United Network for Organ Sharing Ad Hoc Disease Transmission Advisory Committee.
Autorzy:
Theodoropoulos NM; Division of Infectious Diseases & Immunology, University of Massachusetts Medical School, Worcester, MA, USA.
La Hoz RM; Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Wolfe C; Duke University Medical Center, Durham, NC, USA.
Vece G; United Network for Organ Sharing, Richmond, VA, USA.
Bag R; Section of Pulmonary & Critical Care Medicine, UChicago Medicine, Chicago, IL, USA.
Berry GJ; Department of Pathology, Stanford University, Stanford, CA, USA.
Bucio J; Lung and Heart Transplant Programs, UChicago Medicine, Chicago, IL, USA.
Danziger-Isakov L; Department of Pediatrics, Cincinnati Children's Hospital Medical Center &, University of Cincinnati, Cincinnati, OH, USA.
Florescu DF; Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
Goldberg D; Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, FL, USA.
Ho CS; Gift of Hope Organ & Tissue Donor Network, Itasca, IL, USA.
Lilly K; Lifelink Foundation, Tampa, FL, USA.
Malinis M; Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA.
Mehta AK; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.
Nalesnik MA; Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA.
Sawyer R; Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA.
Strasfeld L; Division of Infectious Diseases, Oregon Health & Science University, Portland, OR, USA.
Wood RP; LifeGift, Houston, TX, USA.
Michaels MG; Department of Pediatrics, Division of Pediatric Infectious Diseases, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2021 Feb; Vol. 23 (1), pp. e13458. Date of Electronic Publication: 2020 Sep 22.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B*
Tissue and Organ Procurement*
Advisory Committees ; Hepatitis B Antibodies ; Hepatitis B Core Antigens ; Hepatitis B Surface Antigens ; Hepatitis B virus/immunology ; Humans ; Tissue Donors
Czasopismo naukowe
Tytuł:
Characteristics and outcomes among patients with community-acquired respiratory virus infections during the first year after lung transplantation.
Autorzy:
Mahan LD; Lung Transplant Program, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Kanade R; Lung Transplant Program, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Mohanka MR; Lung Transplant Program, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Bollineni S; Lung Transplant Program, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Joerns J; Lung Transplant Program, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Kaza V; Lung Transplant Program, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Torres F; Lung Transplant Program, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
La Hoz RM; Division of Infectious Disease and Geographic Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Banga A; Lung Transplant Program, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Pokaż więcej
Źródło:
Clinical transplantation [Clin Transplant] 2021 Jan; Vol. 35 (1), pp. e14140. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji:
Journal Article
MeSH Terms:
Community-Acquired Infections/*epidemiology
Graft Rejection/*epidemiology
Lung Transplantation/*adverse effects
Respiratory Tract Infections/*epidemiology
Adolescent ; Adult ; Aged ; Community-Acquired Infections/diagnosis ; Community-Acquired Infections/virology ; Female ; Follow-Up Studies ; Graft Rejection/diagnosis ; Graft Rejection/virology ; Humans ; Male ; Middle Aged ; Prognosis ; Respiratory Tract Infections/diagnosis ; Respiratory Tract Infections/virology ; Retrospective Studies ; Risk Factors ; Texas/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł:
Intestinal parasites including Cryptosporidium, Cyclospora, Giardia, and Microsporidia, Entamoeba histolytica, Strongyloides, Schistosomiasis, and Echinococcus: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Autorzy:
La Hoz RM; Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
Morris MI; Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida.
Pokaż więcej
Corporate Authors:
AST Infectious Diseases Community of Practice
Źródło:
Clinical transplantation [Clin Transplant] 2019 Sep; Vol. 33 (9), pp. e13618. Date of Electronic Publication: 2019 Jun 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anthelmintics/*therapeutic use
Donor Selection/*standards
Intestinal Diseases, Parasitic/*diagnosis
Intestinal Diseases, Parasitic/*drug therapy
Organ Transplantation/*adverse effects
Practice Guidelines as Topic/*standards
Tissue Donors/*supply & distribution
Animals ; Cryptosporidiosis/diagnosis ; Cryptosporidiosis/drug therapy ; Cryptosporidiosis/etiology ; Cryptosporidium/isolation & purification ; Cyclospora/isolation & purification ; Cyclosporiasis/diagnosis ; Cyclosporiasis/drug therapy ; Cyclosporiasis/etiology ; Echinococcosis/diagnosis ; Echinococcosis/drug therapy ; Echinococcosis/etiology ; Echinococcus/isolation & purification ; Entamoeba histolytica/isolation & purification ; Entamoebiasis/diagnosis ; Entamoebiasis/drug therapy ; Entamoebiasis/etiology ; Giardia/isolation & purification ; Giardiasis/diagnosis ; Giardiasis/drug therapy ; Giardiasis/etiology ; Helminths/isolation & purification ; Humans ; Intestinal Diseases, Parasitic/etiology ; Microsporidia/isolation & purification ; Microsporidiosis/diagnosis ; Microsporidiosis/drug therapy ; Microsporidiosis/etiology ; Schistosoma/isolation & purification ; Schistosomiasis/diagnosis ; Schistosomiasis/drug therapy ; Schistosomiasis/etiology ; Societies, Medical ; Strongyloides/isolation & purification ; Strongyloidiasis/diagnosis ; Strongyloidiasis/drug therapy ; Strongyloidiasis/etiology ; Transplant Recipients
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies